Skip to main content

Elmiron Vision Lawsuits Near 200 In The MDL

Elmiron Vision Lawsuits Near 200 In The MDL

Elmiron Vision Lawsuits Near 200 In The MDL

Introduction

On March 29, a Case Management Order (CMO) was issued, which indicated that as of March, 196 cases over Elmiron vision problems were filed in federal and state courts nationwide.

The CMO also noted that there are 171 cases pending in federal multidistrict litigation (MDL), and another 25 cases filed in New Jersey and Pennsylvania state courts combined.

Additionally, it also asked the parties to meet and actively discuss proposed orders and stipulations to advance the litigation, which should include:

  • An Order addressing plaintiff fact sheets (PFS), defense fact sheets (DFS), and a corresponding electronic vendor.
  • A Scheduling Order, including the future trial date.
  • A protocol governing remote depositions.

Elmiron, also known by its generic name pentosan polysulfate sodium (PPS), is a medication prescribed to treat interstitial cystitis (IC). Many cases of pigmentary maculopathy, which involves changes to the retina, causing vision loss and impairment, have been reported among its users, mostly by individuals who have been using it for three years or longer.

A study was also published last month in the medical journal Current Opinion in Ophthalmology in which researchers indicated that one out of every five long-term users of Elmiron is prone to be left with retinal maculopathy.

In January, U.S. District Judge Brian R. Martinotti, presiding over all Elmiron lawsuits, appointed a 25-member committee to serve in various leadership positions in the MDL. The committee would include three co-lead counsel and one liaison counsel, seven Executive Committee members, and 14 Steering Committee members.

The next case management conference is scheduled for Wednesday, April 14, 2021.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!